<DOC>
<DOCNO>EP-1051421</DOCNO> 
<TEXT>
<INVENTION-TITLE>
COMPOUNDS CONTAINING BORON FOR ELECTRON MICROSCOPY AND FOR BORON NEUTRON-CAPTURE THERAPY
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K4900	A61P4300	A61K4900	A61K4100	A61K4100	C07F502	A61P4300	C07F500	A61P3500	A61P3500	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61P	A61K	A61K	A61K	C07F	A61P	C07F	A61P	A61P	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K49	A61P43	A61K49	A61K41	A61K41	C07F5	A61P43	C07F5	A61P35	A61P35	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to a compound which contains boron and which comprises the following general formula (1), in which Cb represents carborane, R
<
2
>
 and R
<
3
>
, independent of one another, represent a hydrogen atom or an organic radical, and R and R
<
1
>
, independent of one another, represent a hydrogen atom or an organic group, or R and R
<
1
>
 form a carbonyl group with the carbon atom on which R and R
<
1
>
 are bound. The invention also relates to a method for producing a compound containing boron and to the application of the same.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
DEUTSCHES KREBSFORSCH
</APPLICANT-NAME>
<APPLICANT-NAME>
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
RADDATZ STEFAN
</INVENTOR-NAME>
<INVENTOR-NAME>
SPIESS EBERHARD
</INVENTOR-NAME>
<INVENTOR-NAME>
TRENDELENBURG MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
TROESTER HELMUT
</INVENTOR-NAME>
<INVENTOR-NAME>
WIESSLER MANFRED
</INVENTOR-NAME>
<INVENTOR-NAME>
RADDATZ, STEFAN
</INVENTOR-NAME>
<INVENTOR-NAME>
SPIESS, EBERHARD
</INVENTOR-NAME>
<INVENTOR-NAME>
TRENDELENBURG, MICHAEL
</INVENTOR-NAME>
<INVENTOR-NAME>
TROESTER, HELMUT
</INVENTOR-NAME>
<INVENTOR-NAME>
WIESSLER, MANFRED
</INVENTOR-NAME>
</INVENTORS>
<CLAIMS>
A boron-containing compound which comprises the
following general formula (1)



in which

Cb represents carborane,

R
2
 and R
3
, independent of one another, represent a
hydrogen atom or an organic radical, and

R and R
1
, independent of one another, represent a
hydrogen atom or an organic group, or R and R
1
 form a
carbonyl group with the carbon atom to which they are

bound.
The compound according to claim 1, 
characterized in
that
 the carborane is a 1,2-dicarba-
closo
-dodecaborane(12).
The compound according to claim 1 or 2, 
characterized
in that
 a spacer and/or a solubility-modulating
compound is bound to the carborane.
The compound according to claim 3, 
characterized in
that
 the solubility-modulating compound is glucose.
The compound according to claim 3 or 4, 
characterized
in that
 a solubility-modulating compound is bound to
one up to all carboranes. 
The compound according to any of claims 1 to 5,

characterized in that
 the organic residue for R
2
 and R
3

is a COOR
4
 group or together with the carbon atoms to
which they are bound form a 6-membered ring.
The compound according to claim 6, 
characterized in
that
 for forming the 6-membered ring R
2
 and R
3
 are
selected from the group consisting of:


The compound according to any of claims 1 to 7,

characterized in that
 the organic group denoting R
and/or R
1
 is a C2 to C10 alkyl group bound via an ether
bridge.
The compound according to claim 8, 
characterized in
that
 a phosphate group is bound to the C2 to C10 alkyl
group.
The compound according to claim 9, 
characterized in
that
 a mono-, oligo-, or polynucleotide is bound to the
phosphate group.
A method of producing a compound according to any of
claims 1 to 10, 
characterized in that
 a decaborane (14)
is reacted with a compound of formula (4)


Use of a compound according to any of claims 1 to 10 as
a boron-containing marker for the energy-filtering

transmission electron microscopy or for the boron
neutron-capture therapy for treating tumoral diseases.
</CLAIMS>
</TEXT>
</DOC>
